Dr. Brownlee is chief pharmacy officer at University of Iowa Health Care and chief administrative officer for the health system’s university campus, with responsibility for pharmacy, pathology, radiology, supply chain, materials management, employee health, and food and nutrition operations. His work impacts 2,600 hospital-based employees, $8 billion in annual gross patient revenue and $1.4 billion in operating expenses. He served as clinical ancillary services lead for the system’s $525.6 million North Liberty (Iowa) campus, which opened in April 2025, and oversaw the opening of a new 50,000-square-foot centralized pharmacy fill location supporting the statewide clinical enterprise. Dr. Brownlee was executive sponsor for the $280 million acquisition and integration of Mission Cancer + Blood, an 18-physician oncology practice operating in 22 Central Iowa locations. Additionally, he served as clinical ancillary services lead for the January 2024 bankruptcy acquisition of Mercy Hospital Iowa City. He led his team in growing ambulatory pharmacy net income from $3.6 million to $190 million through the targeted expansion of ambulatory care and contract pharmacy programs. He co-led pump integration between BD CareFusion Alaris pumps and Epic, making UI Health Care the first site in the world to go live with the technology, and directed Iowa’s first American Society of Health-System Pharmacists-accredited pharmacy technician training program. He also serves as associate dean for clinical education at the University of Iowa College of Pharmacy and has been an American Society of Health-System Pharmacists fellow since 1997.
